Personal information

Australia

Activities

Employment (7)

The Royal Melbourne Hospital: Parkville, VIC, AU

2022-02 to present | Basic Physician Trainee
Employment
Source: Self-asserted source
Victor S. Lin

Peter MacCallum Cancer Institute: Melbourne, VIC, AU

2018-06-01 to present | Honorary Research Affiliate (Department of Clinical Haematology)
Employment
Source: Self-asserted source
Victor S. Lin

Peter MacCallum Cancer Centre: Melbourne, Victoria, AU

2023-08 to 2023-11 | Clinical Haematology Registrar (Department of Clinical Haematology)
Employment
Source: Self-asserted source
Victor S. Lin

The Royal Melbourne Hospital: Parkville, VIC, AU

2021-01 to 2022-01 | Intern
Employment
Source: Self-asserted source
Victor S. Lin

Walter and Eliza Hall Institute of Medical Research: Melbourne, VIC, AU

2019-04-01 to 2020-12-31 | Postgraduate Research Student (Blood Cells and Blood Cancer Division)
Employment
Source: Self-asserted source
Victor S. Lin

Walter and Eliza Hall Institute of Medical Research: Melbourne, VIC, AU

2016-01-01 to 2017-01-31 | Undergraduate Research Student (Cancer and Haematology Division)
Employment
Source: Self-asserted source
Victor S. Lin

Peter Doherty Institute: Melbourne, Victoria, AU

2016-01-01 to 2016-01-31 | Summer Research Student (Immunology Division)
Employment
Source: Self-asserted source
Victor S. Lin

Education and qualifications (5)

University of Melbourne: Melbourne, Victoria, AU

2023 to present | Graduate Diploma of Clinical Ultrasound
Education
Source: Self-asserted source
Victor S. Lin

The University of Sydney School of Medicine: Sydney, NSW, AU

2022 to 2023 | Master of Medicine (Critical Care Medicine)
Education
Source: Self-asserted source
Victor S. Lin

The University of Sydney: Sydney, NSW, AU

2020 to 2021 | Master of Public Health (Sydney School of Public Health)
Education
Source: Self-asserted source
Victor S. Lin

The University of Melbourne: Melbourne, VIC, AU

2017 to 2020 | Doctor of Medicine (Melbourne Medical School)
Education
Source: Self-asserted source
Victor S. Lin

University of Melbourne: Melbourne, VIC, AU

2014 to 2016 | Bachelor of Biomedicine
Education
Source: Self-asserted source
Victor S. Lin

Professional activities (5)

7NEWS Young Achiever Awards: Melbourne, Victoria, AU

2023-04 | Victorian Young Achiever of the Year
Distinction
Source: Self-asserted source
Victor S. Lin

Walter and Eliza Hall Institute of Medical Research: Melbourne, VIC, AU

2016 | Metcalf Scholarship
Distinction
Source: Self-asserted source
Victor S. Lin

The University of Melbourne: Melbourne, VIC, AU

2016 | Department of Microbiology and Immunology 3rd Year Microbiology Prize
Distinction
Source: Self-asserted source
Victor S. Lin

The University of Melbourne: Melbourne, VIC, AU

2014 | Melbourne National Scholarship
Distinction
Source: Self-asserted source
Victor S. Lin

The University of Melbourne: Melbourne, VIC, AU

2014 | Chancellor's Scholar
Distinction
Source: Self-asserted source
Victor S. Lin

Works (9)

Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon

Blood Advances
2024-03-26 | Journal article
Contributors: Thomas E. Lew; Rory Bennett; Victor S. Lin; Ashley Whitechurch; Sasanka M. Handunnetti; Paula Marlton; Yandong Shen; Stephen P. Mulligan; Joshua Casan; Piers Blombery et al.
Source: check_circle
Crossref

Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL

Blood
2022-02-24 | Journal article
Contributors: Piers Blombery; Thomas E. Lew; Michael A. Dengler; Ella R. Thompson; Victor S. Lin; Xiangting Chen; Tamia Nguyen; Ashish Panigrahi; Sasanka M. Handunnetti; Dennis A. Carney et al.
Source: check_circle
Crossref

International Forum on the Management of Major Haemorrhage: Responses

Vox Sanguinis
2022-01-20 | Journal article
Part of ISSN: 0042-9007
Part of ISSN: 1423-0410
Source: Self-asserted source
Victor S. Lin

International Forum on the Management of Major Haemorrhage: Summary

Vox Sanguinis
2022-01-20 | Journal article
Part of ISSN: 0042-9007
Part of ISSN: 1423-0410
Source: Self-asserted source
Victor S. Lin

Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition

Blood Advances
2021-10-26 | Journal article
Contributors: Thomas E. Lew; Victor S. Lin; Edward R. Cliff; Piers Blombery; Ella R. Thompson; Sasanka M. Handunnetti; David A. Westerman; Bryone J. Kuss; Constantine S. Tam; David C. S. Huang et al.
Source: check_circle
Crossref

BH3 Mimetics for the Treatment of B-Cell Malignancies—Insights and Lessons from the Clinic

Cancers
2020-11-12 | Journal article
Contributors: Victor S. Lin; Zhuo-Fan Xu; David C. S. Huang; Rachel Thijssen
Source: check_circle
Crossref

BTK inhibitor therapy is effective in patients with CLL resistant to venetoclax

Blood
2020-06-18 | Journal article
Contributors: Victor S. Lin; Thomas E. Lew; Sasanka M. Handunnetti; Piers Blombery; Tamia Nguyen; David A. Westerman; Bryone J. Kuss; Constantine S. Tam; Andrew W. Roberts; John F. Seymour et al.
Source: check_circle
Crossref

Undetectable peripheral blood MRD should be the goal of venetoclax in CLL, but attainment plateaus after 24 months

Blood Advances
2020-01 | Journal article
Part of ISSN: 2473-9529
Contributors: Thomas E. Lew; Mary Ann Anderson; Victor S. Lin; Sasanka M. Handunnetti; Neil A. Came; Piers Blombery; David A. Westerman; Meaghan Wall; Constantine S. Tam; Andrew W. Roberts et al.
Source: Self-asserted source
Victor S. Lin via Crossref Metadata Search
grade
Preferred source (of 2)‎

Venetoclax for the treatment of mantle cell lymphoma

Annals of Lymphoma
2019-04 | Journal article
Part of ISSN: 2616-2695
Source: Self-asserted source
Victor S. Lin